vancomycin strides 125 mg
strides pharma (cyprus) limited - vankomycinhydroklorid - kapsel, hard - 125 mg
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
abboticin 250 mg
amdipharm limited (1) - erytromycinstearat - tablett, drasjert - 250 mg
alluzience 200 e/ ml
ipsen pharma - botulinumtoksin type a - haemagglutininkompleks - injeksjonsvæske, oppløsning - 200 e/ ml
dysport 300 e
institut produits synthèse (ipsen) ab - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 300 e
clindabactin 440 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 440 mg
clindabactin 55 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 55 mg
clindabactin 220 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 220 mg
bacimycin 500 ie/ g / 5 mg/ g
teva b.v. - sinkbacitracin / klorheksidindiacetat - salve - 500 ie/ g / 5 mg/ g
brulidine 0.15 %
sanofi-aventis norge (3) - dibrompropamidindiisetionat - krem - 0.15 %